Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are of legal adult age and have been diagnosed with AML (a type of blood cancer), ALL (another type of blood cancer), or MDS (a bone marrow disorder), at any stage of their treatment
- People who have signed the required consent form for the trial
- People who are covered by a social security system
Who may not be able to join:
- People who are under 18 years of age (minors)
- Adults who are under legal guardianship
- People who have a protected legal status (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pierre Peterlin, Nantes University Hospital
Phone: +33 2 40 08 32 71
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterization of the tumor and its microenvironment for AML, ALL or MDS in order to identify novel biomarkers or therapeutic targets
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.